SUPN
SUPERNUS PHARMACEUTICALS, INC.
+1.77 (+4.28%)43.15USD236K成交股數2.5B市值–本益比(近四季)3.0股價營收比+32.4%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 219M+32% | 208M+39% | 212M+20% | 192M+14% | 165M+15% | 150M-9% | 176M+14% | 168M+24% | 144M | 164M | 154M | 136M |
| 營業成本 | 33.7M | 23.4M | 23.0M | 19.0M | 16.8M | 15.8M | 17.6M | 17.9M | 16.3M | 19.6M | 19.6M | 21.1M |
| 毛利 | 185M+25% | 184M+37% | 189M+19% | 173M+15% | 149M+17% | 134M-7% | 158M+18% | 150M+31% | 127M | 145M | 134M | 114M |
| 毛利率 | 84.6% | 88.7% | 89.1% | 90.1% | 89.8% | 89.5% | 90.0% | 89.4% | 88.6% | 88.1% | 87.3% | 84.4% |
| 研發費用 | 29.5M | 39.4M | 27.8M | 29.4M | 22.1M | 26.9M | 29.0M | 26.2M | 24.9M | 23.3M | 22.7M | 24.4M |
| 銷售管理費用 | 134M | 125M | 122M | 180M | 93.6M | 89.9M | 69.8M | 85.9M | 86.5M | 81.3M | 82.7M | 86.8M |
| 營業利益 | −58.0M-577% | −8.3M-19% | −3.9M-110% | −60.2M-367% | 12.1M-485% | −10.3M+930% | 40.8M+402% | 22.6M-228% | −3.2M | −996K | 8.1M | −17.6M |
| 營業利益率 | -26.5% | -4.0% | -1.9% | -31.4% | 7.3% | -6.8% | 23.2% | 13.4% | -2.2% | -0.6% | 5.3% | -13.0% |
| 稅後淨利 | −58.4M-359% | −2.3M-81% | −4.2M-111% | −45.1M-327% | 22.5M+18044% | −11.8M-1120% | 38.5M-341% | 19.9M-2497% | 124K | 1.2M | −16.0M | −831K |
| 淨利率 | -26.6% | -1.1% | -2.0% | -23.5% | 13.6% | -7.9% | 21.9% | 11.8% | 0.1% | 0.7% | -10.4% | -0.6% |
| 稀釋 EPS | -1.01-353% | -0.04-81% | -0.07-110% | -0.80-322% | 0.40 | -0.21-625% | 0.69-338% | 0.36-1900% | 0.00 | 0.04 | -0.29 | -0.02 |
| 稀釋股數 | 58.1M | 57.6M | 56.5M | 56.6M | 56.6M | 55.9M | 56.0M | 55.7M | 55.6M | 55.5M | 54.6M | 54.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 180M | 185M | 128M | 151M | 145M | 116M | 31.7M | 52.1M | 63.4M | 75.1M | 95.0M | 24.7M |
| 應收帳款 | 212M | 182M | 188M | 171M | 141M | 146M | 145M | 152M | 148M | 144M | 142M | 137M |
| 存貨 | 107M | 111M | 112M | 107M | 44.0M | 49.4M | 64.0M | 68.2M | 75.1M | 77.4M | 83.5M | 90.6M |
| 總資產 | 1.4B | 1.5B | 1.5B | 1.4B | 1.4B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 397M | 424M | 391M | 370M | 319M | 317M | 336M | 358M | 375M | 356M | 373M | 373M |
| 股東權益 | 1.0B | 1.1B | 1.1B | 1.0B | 1.1B | 1.0B | 1.0B | 957M | 929M | 922M | 912M | 920M |
| 負債比 | 27.8% | 28.2% | 26.9% | 26.1% | 23.0% | 23.5% | 25.0% | 27.2% | 28.7% | 27.9% | 29.0% | 28.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 66.5M+117% | – | – | – | 30.6M | – | – | 38.4M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 327K | – | – | 248K | – | – | – |
| 自由現金流 | – | 66.5M+120% | – | – | – | 30.3M | – | – | 38.2M | – | – | – |
| 折舊攤銷 | 400K | 26.1M | 70.2M | 500K | 500K | 20.4M | 600K | 600K | 20.7M | 63.1M | 600K | 600K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 32.0% | – | – | – | 20.2% | – | – | 26.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 719M
| Reportable | 719M | 100.0% | +8.6% |
|---|
產品／服務2025 年度 · 1.3B
| 產品 | 627M | 46.6% | -1.8% |
|---|---|---|---|
| Qelbree | 305M | 22.6% | +26.3% |
| GOCOVRI | 147M | 10.9% | +12.2% |
| Collaboration Revenue | 53.0M | 3.9% | – |
| APOKYN | 47.8M | 3.6% | -35.4% |
| Trokendi Xr | 42.4M | 3.2% | -32.9% |
| Oxtellar XR | 40.7M | 3.0% | -59.1% |
| Royalty License And Other Revenue | 39.4M | 2.9% | +63.4% |
| Manufactured Product Other | 26.9M | 2.0% | -7.2% |
| ONAPGO | 17.3M | 1.3% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 719M | +8.6% | −38.6M | -5.4% | -0.68 | 46.0M |
| FY2024 | 662M | +8.9% | 73.9M | 11.2% | 1.32 | 171M |
| FY2023 | 608M | -8.9% | 1.3M | 0.2% | 0.02 | 111M |
| FY2022 | 667M | +15.1% | 60.7M | 9.1% | 1.04 | 116M |
| FY2021 | 580M | +11.4% | 53.4M | 9.2% | 0.98 | – |
| FY2020 | 520M | +32.5% | 127M | 24.4% | 2.36 | 135M |
| FY2019 | 393M | -3.9% | 113M | 28.8% | 2.10 | 140M |
| FY2018 | 409M | – | 111M | 27.1% | 2.05 | 128M |